Webinar: Overcoming Difficulties In GPCR Antibody Discovery Using Biocytogen’s Renmice-Based Platform

Our webinar “Overcoming Difficulties In GPCR Antibody Discovery Using Biocytogen’s Renmice-Based Platform” was live at 11:00 AM EDT on Aug 30th, 2023. 

About the Webinar

GPCRs (G protein-coupled receptor) are the most abundant membrane protein in the human genome, and are targeted by approximately one-third of drugs on the market. However, the difficulty in antigen preparation and novel GPCR-targeting antibody screening has posed significant challenges in the field of GPCR antibody discovery. In this webinar, Dr. Yanan Guo will outline how our target knock-out RenMice and established GPCR antibody discovery platform can enable efficient GPCR antibody discovery and development, with a focus on our leading CCR8 program.

Speaker

Yanan Guo, Ph.D.

Director of Antibody Therapeutics, Biocytogen Institute for Therapeutic Innovations, Biocytogen Pharmaceuticals

Panelist

Toru Kanke, Ph.D.

CEO, LiberoThera, Co., Ltd.

Moderator

Jenna Frame, PhD 

Sr. Manager, Scientific Communications & Marketing, Biocytogen Boston

Watch the webinar recording: Overcoming Difficulties In GPCR Antibody Discovery Using Biocytogen’s Renmice-Based Platform